The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
本发明涉及式(I)的化合物及其药学上可接受的盐和溶剂,它们是S
SAO活性的
抑制剂。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物治疗或预防抑制S
SAO活性有益的医疗状况,例如炎症性疾病和免疫障碍。